Cancer immunotherapy with interleukin-2-activated natural killer cells.

Abstract

Natural killer (NK) cells are a subset of lymphocytes with a distinct morphologic appearance (large granular lymphocytes [LGL]) and the ability to kill virally infected and tumor targets but to spare most normal cells. NK cells respond to a variety of biologic agents, such as interleukin-2 (IL-2), or interferons, by upregulation of cytolytic, secretory, and… (More)

Topics

Cite this paper

@article{Basse2002CancerIW, title={Cancer immunotherapy with interleukin-2-activated natural killer cells.}, author={Per H. Basse and T L Whiteside and Ronald B. Herberman}, journal={Molecular biotechnology}, year={2002}, volume={21 2}, pages={161-70} }